FREYR Battery
FREY
$1.530 -2.55% Quote
Exchange NYSE Sector Industrials Industry Electrical Equipment Parts
Q2 2024
Reported
Published: Aug 9, 2024

Data: Financial Modeling Prep

Company Status Snapshot

Fast view of the latest quarter outcome for FREY

Report Date

Aug 9, 2024

Quarter Q2 2024

Revenue

N/A

YoY: N/A

EPS

-0.19

YoY: -5.6%

Market Move

-2.55%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Net Income

-26.99M

YoY: -6.7%

FREY
Company FREY

Swipe to view all report sections

Executive Summary

FREYR Battery reported its QQ2 2024 results with no disclosed revenue for the quarter, but a clear cash-burn profile driven by scale-up costs as its European battery cell facilities advance toward commercial production. The company posted a cost of revenue of 2.822 million USD and a gross loss of 2.822 million USD, accompanied by total operating expenses of 30.778 million USD. EBITDA was negative 28.233 million USD and net income came in at negative 26.987 million USD, or -0.19 per share. The quarter underscores FREY’s ongoing transition from a development-stage manufacturer to a ramping production platform, with near-term profitability still contingent on meaningful revenue recognition and unit-cost reductions as capacity comes online.

Despite the current losses, FREY maintains a substantial liquidity cushion. Cash and cash equivalents stood at approximately 219.6 million USD, with total cash and short-term investments around 223.6 million USD and a net cash position of roughly -199.3 million USD. Free cash flow for the period was negative 35.6 million USD, and operating cash flow was negative 27.98 million USD, reflecting heavy upfront capex and working-capital investments typical of early-stage gigafactory scale-ups. The balance sheet remains robust, with total assets of 644.4 million USD and total stockholders’ equity of 561.6 million USD, underscoring a strong asset base to support planned capacity expansions. The current ratio and cash ratio are both reported at 6.63 and 6.21 respectively, signaling ample liquidity to fund near-term growth initiatives.

From a qualitative standpoint, the dominant theme is execution risk surrounding ramp timing and cost control as FREY transitions from a development phase to high-rate production, particularly in Europe’s regulatory and subsidy-driven environment. The earnings trajectory will hinge on (1) the timing and cost efficiency of new cell facilities, (2) the degree to which FREY converts capacity into revenue, and (3) the ability to secure favorable contractual arrangements or subsidies that shorten payback periods. Management commentary (when available) would be critical to confirm expected ramp dates, capital allocation priorities, and any updates to strategic partnerships or customers. Given the lack of revenue data in QQ2, the key near-term focus for investors is the trajectory of revenue realization and operating leverage as European facilities come online.

Key Performance Indicators

Operating Income
Increasing
-30.78M
QoQ: 11.56% | YoY: 9.55%
Net Income
Decreasing
-26.99M
QoQ: 5.45% | YoY: -6.74%
EPS
Decreasing
-0.19
QoQ: 5.00% | YoY: -5.56%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 0.24 -0.08 +0.0% View
Q1 2025 0.00 -0.11 +0.0% View
Q4 2024 2.94 -2.59 +0.0% View
Q3 2024 0.00 -0.20 +0.0% View
Q2 2024 0.00 -0.19 +0.0% View